We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $1.67B
1-Year Est. Return 7.53%
This Fund
S&P 500
This Quarter Est. Return
-24.36%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
AUM
$4.79B
AUM Growth
-$1.68B
Cap. Flow
+$133M
Cap. Flow %
2.78%
Top 10 Hldgs %
74.69%
Holding
80
New
4
Increased
7
Reduced
9
Closed
16

Top Sells

Rank Stock Value
1
LEGN icon
Legend Biotech
LEGN
+$192M
2
ONON icon
On Holding
ONON
+$178M
3
ERAS icon
Erasca
ERAS
+$73.6M
4
LI icon
Li Auto
LI
+$69.2M
5
AMG icon
Affiliated Managers Group
AMG
+$55.1M

Sector Composition

Rank Sector Weight
1 Healthcare 37.67%
2 Consumer Discretionary 35.71%
3 Technology 14.57%
4 Communication Services 5.27%
5 Consumer Staples 3.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONC
1
BeOne Medicines Ltd
ONC
$33.9B
$1.03B 21.55%
5,472,259
JD icon
2
JD.com
JD
$43.3B
$488M 10.19%
8,434,471
+3,667,164
+77% +$249M
DASH icon
3
DoorDash
DASH
$85.6B
$455M 9.5%
3,881,700
+2,585,400
+199% +$280M
CRM icon
4
Salesforce
CRM
$151B
$450M 9.39%
2,119,037
+189,161
+10% +$40.7M
LEGN icon
5
Legend Biotech
LEGN
$3.69B
$252M 5.26%
6,936,617
-4,868,308
-41% -$192M
ONON icon
6
On Holding
ONON
$12.4B
$235M 4.9%
9,300,000
-6,673,750
-42% -$178M
VIPS icon
7
Vipshop
VIPS
$7.19B
$199M 4.16%
22,150,493
+13,186,741
+147% +$116M
IQ icon
8
iQIYI
IQ
$1.2B
$175M 3.66%
38,648,477
SE icon
9
Sea Limited
SE
$66.5B
$174M 3.63%
1,453,300
+215,500
+17% +$30.4M
MDLZ icon
10
Mondelez International
MDLZ
$84B
$117M 2.44%
1,862,164
NBP
11
NovaBridge Biosciences American Depositary Shares
NBP
$195M
$117M 2.44%
7,182,850
CTKB icon
12
Cytek Biosciences
CTKB
$573M
$94.4M 1.97%
8,757,030
DIDI
13
DELISTED
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
$92.1M 1.92%
+36,834,320
New +$145M
LI icon
14
Li Auto
LI
$14.5B
$64.4M 1.35%
2,496,550
-2,510,750
-50% -$69.2M
GOSS icon
15
Gossamer Bio
GOSS
$91.2M
$64.4M 1.34%
7,420,974
BEKE icon
16
KE Holdings
BEKE
$17.7B
$64.1M 1.34%
5,182,364
+170,264
+3% +$3.03M
YMM icon
17
Full Truck Alliance
YMM
$9.85B
$64M 1.34%
+9,590,942
New +$77.6M
PLTK icon
18
Playtika
PLTK
$1.53B
$63.4M 1.32%
3,280,699
ENFN
19
DELISTED
Enfusion, Inc.
ENFN
$63.3M 1.32%
4,975,183
CPNG icon
20
Coupang
CPNG
$27B
$59.2M 1.24%
3,350,400
+925,200
+38% +$19.8M
BBIO icon
21
BridgeBio Pharma
BBIO
$16.6B
$54.4M 1.14%
5,362,014
UBER icon
22
Uber
UBER
$143B
$39.7M 0.83%
1,114,000
ARGX icon
23
argenx
ARGX
$55.1B
$37.8M 0.79%
120,000
TSM icon
24
TSMC
TSM
$1.99T
$37.6M 0.78%
360,495
KNSA icon
25
Kiniksa Pharmaceuticals
KNSA
$6.15B
$29M 0.61%
2,920,023

Similar funds

HHLR Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, HHLR Advisors held 80 positions worth $4.79B, down 26% from $6.47B the previous quarter. Its ten largest holdings account for 75% of the portfolio.

HHLR Advisors's Q1 2022 filing shows 4 new, 7 increased, 9 reduced and 16 closed positions. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 36,834,320 shares worth $92.1M. The largest sale was Legend Biotech, an estimated $192M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 48% a quarter earlier, followed by Consumer Discretionary and Technology.

  • HHLR Advisors's largest Q1 2022 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 36,834,320 shares worth $92.1M.
  • HHLR Advisors added most to DoorDash in Q1 2022, an estimated $280M increase.
  • HHLR Advisors's biggest Q1 2022 reduction was Legend Biotech, cutting an estimated $192M.
  • HHLR Advisors fully exited Erasca in Q1 2022, selling an estimated $73.6M.
  • HHLR Advisors's ten largest holdings make up 75% of its $4.79B portfolio in Q1 2022.
  • HHLR Advisors opened 4 new positions and closed 16 in Q1 2022.
  • HHLR Advisors's portfolio value fell 26% quarter-over-quarter to $4.79B.

Based on HHLR Advisors's 13F filing for Q1 2022, filed 16 May 2022.